Retatrutide is a newly discovered substance that shows promise as a treatment for type 2 diabetes. It functions as a activator of the glucagon-like peptide-1 (GLP-1) receptor, which plays a crucial role in regulating https://rafaelxipf457455.suomiblog.com/semaglutide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes-54774843